Can-Fite BioPharma Ltd. Files 6-K for June 30, 2024
Ticker: CANF · Form: 6-K · Filed: Aug 29, 2024 · CIK: 1536196
| Field | Detail |
|---|---|
| Company | Can-Fite Biopharma LTD. (CANF) |
| Form Type | 6-K |
| Filed Date | Aug 29, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-results, 6-k, foreign-private-issuer
Related Tickers: CANF
TL;DR
Can-Fite BioPharma dropped its Q2 2024 financials in a 6-K filing.
AI Summary
Can-Fite BioPharma Ltd. filed a Form 6-K on August 29, 2024, reporting its financial results for the period ending June 30, 2024. The filing includes financial statements and other information relevant to its status as a foreign private issuer. The company is incorporated in Israel and its fiscal year ends on December 31.
Why It Matters
This filing provides investors with updated financial information for Can-Fite BioPharma, crucial for assessing the company's performance and financial health.
Risk Assessment
Risk Level: low — This is a routine financial filing (6-K) and does not contain new material events or significant financial changes.
Key Numbers
- 20240630 — Reporting Period End (Financial results are for this period)
- 20240829 — Filing Date (Date the report was submitted to the SEC)
Key Players & Entities
- Can-Fite BioPharma Ltd. (company) — Filer of the report
- 20240630 (date) — Reporting period end date
- 20240829 (date) — Filing date
- 001-36203 (other) — SEC File Number
FAQ
What type of report is Can-Fite BioPharma Ltd. filing?
Can-Fite BioPharma Ltd. is filing a Form 6-K, which is a Report of Foreign Private Issuer.
What is the reporting period for this filing?
The Conformed Period of Report is June 30, 2024.
When was this Form 6-K filed with the SEC?
This Form 6-K was filed on August 29, 2024.
Where is Can-Fite BioPharma Ltd. headquartered?
Can-Fite BioPharma Ltd.'s principal executive offices are located at 26 Ben Gurion Street, Ramat Gan, Israel.
Does Can-Fite BioPharma Ltd. file annual reports under Form 20-F or 40-F?
Yes, Can-Fite BioPharma Ltd. files annual reports under Form 20-F, as indicated by the checkmark next to it.
Filing Stats: 475 words · 2 min read · ~2 pages · Grade level 11 · Accepted 2024-08-29 08:46:20
Filing Documents
- ea0212637-6k_canfite.htm (6-K) — 23KB
- ea021263701ex99-1_canfite.htm (EX-99.1) — 81KB
- ea021263701ex99-2_canfite.htm (EX-99.2) — 302KB
- ea021263701ex99-3_canfite.htm (EX-99.3) — 60KB
- 0001213900-24-073573.txt ( ) — 2732KB
- canf-20240630.xsd (EX-101.SCH) — 36KB
- canf-20240630_cal.xml (EX-101.CAL) — 21KB
- canf-20240630_def.xml (EX-101.DEF) — 139KB
- canf-20240630_lab.xml (EX-101.LAB) — 295KB
- canf-20240630_pre.xml (EX-101.PRE) — 145KB
- ea0212637-6k_canfite_htm.xml (XML) — 242KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Date: August 29, 2024 By: /s/ Motti Farbstein Motti Farbstein Chief Executive Officer and Chief Financial Officer 3